Dr Anita Pye PhD

Image of Anita Pye

Institute of Inflammation and Ageing
Research Fellow / Clinical Trials Co-ordinator

Contact details

+44 (0) 121 371 3886
+44 (0) 121 371 3887
Institute of Inflammation and Ageing
College of Medical and Dental Sciences
University of Birmingham
B15 2TT

Anita Pye is a Research Fellow in the Institute of Inflammation and Ageing working in Clinical Trials.


  • PhD 1994
  • BSc (Hons) 1989  


Anita Pye qualified with a BSc (Hons) in Applied Biology from Trent Polytechnic Nottingham in 1989. She went on to study for a PhD at the University of Birmingham. She spent 14 months working at the State University of New York at Buffalo, USA, together with a short period of time at the University of Amsterdam, The Netherlands as part of her research looking at non-typeable Haemophilus influenzae in chronic lung disease.

Anita Pye is responsible for overseeing the daily running of a microbiology research laboratory which processes samples from specialist outpatient clinics for patients with chronic lung diseases and also serves as a central screening laboratory for international clinical trials. She has experience in all aspects of organisation and administration of large and complex clinical trials including 2 major international, multi-centre clinical trials in alpha-1 antitrypsin deficiency and several trials in patients with COPD and Bronchiectasis. 


Assessment and characterisation of bacterial load in chronic lung diseases, including Bronchiectasis and alpha-1 antitrypsin deficiency. Particular interest in non-typeable Haemophilus influenzae and Pseudomonas aeruginosa.

Other activities

Involved with the organisation of the biennial international, multi-disciplinary conferences on COPD held at the International Convention Centre, Birmingham since 2000.


Stone H, Pye A and Stockley RA (2014) Disease associations in alpha-1-antitrypsin deficiency. Respir Med 108(2):338-43

Stockley RA and Pye A (2009) Reply to: Brusse-Keizer MGJ, et al. Relation of sputum colour to bacterial load in acute exacerbations of COPD. Respir Med 103(6):939-40

Pye A, Hill SL, Bharadwa P and Stockley RA (2008) Effect of storage and postage on recovery and quantitation of bacteria in sputum samples. J Clin Pathol 61(3):352-4

Stockley RA, O’Brien C, Pye A and Hill SL (2000) Relationship of Sputum color to nature and outpatient management of acute exacerbations of COPD. Chest 117(6):1638-45

Bilton D, Pye A, Johnson MM, Mitchell JL, Dodd M, Webb AK, Stockley RA and Hill SL (1995) The isolation and characterisation of non-typeable Haemophilus influenzae from the sputum of adult cystic fibrosis patients. Eur Respir J 8(6):948-53

Pye A, Stockley RA and Hill SL (1995) Simple method for quantifying viable bacterial numbers in sputum. J Clin Pathol 48(8):719-24

Llewellyn-Jones CG, Johnson MM, Mitchell JL, Pye A, Okafor VC, Hill SL and Stockley RA (1995) In vivo study of indomethacin in bronchiectasis: effect on neutrophil function and lung secretion. Eur Respir J 8(9):1479-87

Klingman KL, Pye A, Murphy TF and Hill SL (1995) Dynamics of respiratory tract colonization by Branhamella catarrhalis in Bronchiectasis. Am J Respir Crit Care Med 152(3):1072-8

Hill SL, Bilton D, Johnson MM, Pye A, Mitchell JL and Stockley RA (1994) Sputum and serum pharmacokinetics of loracarbef (LY163892) in patients with chronic bronchial sepsis. J Antimicrob Chemother 33(1):129-36